
|Articles|September 24, 2018
- September 2018 Immunization
- Volume 84
- Issue 9
Improving Patients' Understanding of the Clinical Benefit of EPA and DHA Omega-3s
Author(s)David J. Foreman, RPh, ND
Advertisement
FACULTY
David J. Foreman, RPh, ND Author/Medical Expert Herbal Pharmacist Palm Harbor, Florida
EDUCATIONAL OBJECTIVES:
At the completion of this activity, the participant will be able to:
- Explain the mechanism and disease states in which omega-3 supplementation has been shown to have positive outcomes
- Identify the recommended dose of omega-3s for specific patients and disease states
- Examine and understand common barriers to patient utilization of omega-3 supplements
TARGET AUDIENCE: Retail pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: September 10, 2018
EXPIRATION DATE: September 10, 2019
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at
Articles in this issue
over 7 years ago
The Waiting Is the Hardest Partover 7 years ago
New and Novel HIV Medicationsover 7 years ago
Self-Care for Respiratory Issuesover 7 years ago
States Continue to Expand Availability of Telehealthover 7 years ago
Educating Patients About the Dangers of Sharing Rx Medicationsover 7 years ago
When Complying With a Law Enforcement Request Causes ProblemsAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Baxdrostat as First-in-Class Aldosterone Synthase Inhibitor for Hypertension
2
Insulin Deprescribing Utilizing Continuous Glucose Monitoring With Low-Dose Tirzepatide
3
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
4
FDA Approves Immgolis and Immgolis Intri as First Biosimilars to Golimumab Reference Products for RA and UC
5



































































































































